Navigation Links
Idursulfase Is Effective Treatment for Hunter Syndrome

An article reporting results from a pivotal clinical trial that helped gain U.S. Food and Drug Administration approval for the first treatment for Hunter disease has been// published online by the journal Genetics in Medicine.

Lead author is Dr. Joseph Muenzer, an associate professor in the Department of Pediatrics at the UNC School of Medicine. Muenzer led the Phase II/III clinical trial, which found that weekly infusions of idursulfase (recombinant human iduronate-2-sulfatase) are effective in treating the underlying enzyme deficiency in patients with Hunter syndrome.

Based on these results, the FDA on July 24 approved Elaprase, an idursulfase preparation manufactured by Shire Human Genetic Therapies Inc. of Cambridge, Mass.

“For the families of patients with Hunter syndrome, FDA approval of Elaprase gives them hope,” Muenzer said. “Prior to this, they had no hope. These were children who were destined to die in their teenage years and early 20s. Now, they have a treatment that arrests or halts the disease process,” Muenzer said.

Muenzer is recognized as one of the world’s leading experts in Hunter syndrome research and the medical treatment of children with genetic lysosomal storage diseases such as Hunter syndrome.

In his laboratory at UNC, Muenzer created a mouse model for Hunter syndrome that was used in earlier research that demonstrated the potential effectiveness of Elaprase.

Hunter syndrome, known more formally as mucopolysaccharidosis type II or MPS II, is an extremely rare inherited enzyme disorder that occurs almost exclusively in males. People with Hunter syndrome lack the enzyme iduronate-2-sulfatase, which is essential for recycling complex carbohydrates such as glycosaminoglycans, or GAG. The accumulation of GAG in tissues and organs leads to severe problems that can include joint stiffness, breathing difficulties, heart problems, enlargement of the spleen and liver, coarsenin
'"/>




Page: 1 2 3

Related medicine news :

1. New Way to "See" Genes, Evaluate Effectiveness of Gene Therapies Discovered
2. Inhaled Steroids Safe & Effective for Children with Asthma
3. ZD1839 Proves Effective - A Breakthrough in fighting Lung Cancer
4. Fluoride Found Effective in Osteoporosis
5. Aspirin and Warfarin Are Equally Effective for Stroke Prevention
6. Implantable Contact Lens Found Safe and Effective
7. Effective And Economical Agent For Anthrax
8. Stem Cell Transplants May Be Effective For MS Patients
9. Effective therapy for Huntingtons disease
10. Chemotherapy Effective for Bladder Cancer
11. Drug Effective for Vascular Dementia
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Idursulfase Effective Treatment for Hunter Syndrome

(Date:8/28/2015)... ... August 28, 2015 , ... CARF International announced ... residential, counseling, day treatment and intensive family based services. , By pursuing and ... and its pursuit of excellence. As a nonprofit charity for more than 50 ...
(Date:8/28/2015)... ... August 28, 2015 , ... The Quatela Center for ... is the first and only nonsurgical product approved by the Food and Drug Administration ... Quatela and Dr. William Koenig are among the premier cosmetic surgeons ...
(Date:8/28/2015)... ... August 28, 2015 , ... ... its collaboration with coffee connoisseur and Emmy-nominated actress, Sofia Vergara, and unveil the ... revolutionary Thermal Flavor Extraction™ technology, which delivers a variety of sizes and styles ...
(Date:8/28/2015)... ... 2015 , ... The newest therapy to receive orphan drug status for the ... soon, according to educational website Surviving Mesothelioma. Click here to read their article ... mesothelioma last week from the FDA, will now head into Phase I clinical trials ...
(Date:8/28/2015)... ... 28, 2015 , ... Popular review site Top5MillionaireDatingSites.com recently published ... . According to the listings, MillionaireMatch.com bags the top spot while ... spokesperson of Top5MillionaireDatingSites.com said, “This website has been designed to assist ...
Breaking Medicine News(10 mins):Health News:West Ridge Academy Awarded CARF Three-Year Accrediation 2Health News:Non-surgical Treatment to Get Rid of The "Double Chin," Kybella™, Now Available at the Quatela Center for Plastic Surgery 2Health News:Non-surgical Treatment to Get Rid of The "Double Chin," Kybella™, Now Available at the Quatela Center for Plastic Surgery 3Health News:Sofia Vergara Partners With SharkNinja® To Launch The Ninja Coffee Bar™ 2Health News:Sofia Vergara Partners With SharkNinja® To Launch The Ninja Coffee Bar™ 3Health News:Surviving Mesothelioma Puts New Orphan Drug into Perspective in New Article 2Health News:Top5MillionaireDatingSites.com Publishes Its First List of Reviews of the Best Millionaire Dating Sites 2
... and Eliza Hall Institute have been awarded research fellowships ... research. The inaugural five-year Cory Fellowship, sponsored ... Scott and the inaugural five-year Dyson Fellowship, sponsored by ... Blewitt. At a ceremony on 25 February, Nobel ...
... and a German neurologist have recently shown that the brain ... different from the part used when a verb is learnt. ... magnetic resonance, according to an article they have published this ... activates the left fusiform gyrus, while learning verbs switches on ...
... growth, researchers say, , THURSDAY, Feb. 25 (HealthDay News) -- ... say that doses of vitamin B3 -- also known as ... stroke. , Researchers at Henry Ford Hospital found that rats ... growth and new nerve cells in their brains after being ...
... ... & Exposition (ACE10), June 20-24, in Chicago, Illinois. , ... Denver (Vocus) February 25, 2010 -- Speakers have ... (ACE10), June 20-24, in Chicago, Illinois. , ,Denis Hayes will be the highlighted speaker ...
... ... Harvey Weiner, Director, Consulting Services, CGI Federal, first contacted the Metropolitan Washington, DC ... for very personal reasons; his 2-month old daughter Melissa and 3-year old son ... the time of his children’s diagnosis, the average age of survival for a ...
... ... with Genzyme Biosurgery, is pleased to announce a new research grant program to fund ... ... 2010 -- The American Orthopaedic Society for Sports Medicine (AOSSM), in partnership ...
Cached Medicine News:Health News:Fellowship winners make cancer their focus 2Health News:Fellowship winners make cancer their focus 3Health News:Nouns and verbs are learned in different parts of the brain 2Health News:Nouns and verbs are learned in different parts of the brain 3Health News:Vitamin B3 May Help Repair Brain After a Stroke 2Health News:AWWA Announces ACE10 Speakers 2Health News:Cystic Fibrosis Foundation Awards CGI Corporation of the Year 2Health News:Cystic Fibrosis Foundation Awards CGI Corporation of the Year 3Health News:New Osteoarthritis Research Grant Program Initiated by AOSSM and Genzyme Biosurgery 2Health News:New Osteoarthritis Research Grant Program Initiated by AOSSM and Genzyme Biosurgery 3
(Date:8/27/2015)... , Aug. 27, 2015  The Academy of ... and Drug Administration,s (FDA,s) draft guidance and proposed ... and biosimilars, to bear a nonproprietary name with ... been seeking a decision from the FDA on ... health care stakeholders urging the agency to use ...
(Date:8/27/2015)... , Aug. 27, 2015 DURECT Corporation (Nasdaq: ... to present at three upcoming healthcare conferences.  ... CEO, will present at the Rodman & Renshaw Investment ... time. The conference is being held at the St. ... . A live audio webcast of the presentation will ...
(Date:8/27/2015)... 2015 ieCrowd™ today announced the achievement ... of the company,s supplemental oxygen delivery device, Smart ... developed by ieCrowd,s subsidiary Smart Oxygen Solutions TM ... for oxygen based on level of activity.  The ... the Smart Oxygen device would require a series ...
Breaking Medicine Technology:AMCP Is Disappointed in FDA's Draft Guidance and Proposed Rule Calling for Suffix on Nonproprietary Names of Biological Products 2DURECT to Participate in Upcoming Healthcare Conferences 2Smart Oxygen Solutions' Supplemental Oxygen Delivery Device Achieves FDA Regulatory Pathway Milestone 2Smart Oxygen Solutions' Supplemental Oxygen Delivery Device Achieves FDA Regulatory Pathway Milestone 3Smart Oxygen Solutions' Supplemental Oxygen Delivery Device Achieves FDA Regulatory Pathway Milestone 4
... 19 Beijing Goodwill Information and Technology Co., ... in China, and IBM (NYSE: IBM ) ... electronic cardiogram management system in China. This system ... patient information generated from electrocardiography (ECG) examination reports ...
... 19 DrChrono.com , the premier publisher of dynamic ... of its signature iPad EMR platform , which offers ... eRx cuts down errors resulting from misinterpreted handwriting by more ... DrChrono.com CEO and Co-Founder Michael Nusimow. "It is also ...
Cached Medicine Technology:Beijing Goodwill and IBM Team to Improve Detection of Cardiovascular Diseases 2Beijing Goodwill and IBM Team to Improve Detection of Cardiovascular Diseases 3DrChrono.com iPad EMR Unveils Electronic Prescription Feature 2
... Eyebank Database is a multi-page database that ... used by the Eye Bank Association of ... and recipient information, laboratory and specular microscopy ... adverse reaction reports, letters and invoices that ...
... Focus is the one computer system that finally ... Designed from the outset to be a totally ... large or small, that wishes to increase net ... service offered to patients. It has been designed ...
... Vision Express is a powerful, fully automated ... raise productivity, reduce errors, increase profitability, and ... Vision Express program has been designed and ... and point of purchase software. This fully ...
... SDS Recall marketing software enables the efficient ... The module also has many built-in time ... auto capitalization of name fields and numerous ... and accurate data input. The pre-defined options ...
Medicine Products: